Anti-Rh(D) Immunoglobulin Injection from China
Anti-Rh(D) immunoglobulin injection is a blood fraction containing antibodies against the Rh(D) antigen, derived from human plasma. It is administered prophylactically to prevent hemolytic disease of the newborn in Rh-negative mothers. This product is classified under tariff item 3002.12.00 as an antiserum prepared for therapeutic use.
Duty Rate — China → Canada
0%
Import Tips
• Include the product monograph and proof of Health Canada approval for the therapeutic use
• Ensure the product is packaged for retail sale or as a measured dose, which may affect classification
• Verify that the product is not a diagnostic reagent, which would fall under heading 38.22